Compass Chiropractic and Massage

Fatigue Syndrome Associated with GLP-1 Medications: Understanding the Link

Est. Reading: 2 minutes

Fatigue Syndrome Associated with GLP-1 Medications: Understanding the Link

Introduction

Glucagon-like peptide-1 (GLP-1) receptor agonists have become a cornerstone in the management of type 2 diabetes and obesity. These medications, including semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and others, offer significant benefits in glycemic control and weight loss. However, as their use becomes more widespread, a growing number of patients report experiencing fatigue—a symptom that can be debilitating and, in some cases, overlooked in clinical practice.

This article explores the phenomenon of fatigue associated with GLP-1 receptor agonists, its potential mechanisms, and strategies for healthcare providers and patients to manage this emerging side effect.

What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists mimic the action of the endogenous incretin hormone GLP-1. They stimulate insulin secretion in response to meals, suppress glucagon release, slow gastric emptying, and promote satiety. These effects lead to improved blood glucose control and significant weight loss. Their benefits have also extended to cardiovascular risk reduction, making them a popular option for many patients with metabolic syndrome.

Emerging Concern: Fatigue and GLP-1 Agonists

Fatigue is not listed as a common or serious adverse effect in the product labels of GLP-1 medications. However, real-world patient experiences and some observational reports suggest that fatigue—both physical and mental—can occur with the initiation or continued use of these drugs. The symptom may be transient or persistent, and it can significantly impact a patient’s quality of life and adherence to therapy.

Possible Mechanisms Behind GLP-1-Induced Fatigue

  1. Caloric Deficit and Weight Loss
    • Rapid weight loss, common with GLP-1 therapy, can lead to a caloric deficit that may cause temporary fatigue, especially if nutritional intake is insufficient.
  2. Delayed Gastric Emptying
    • By slowing digestion, GLP-1 agonists can cause early satiety and reduced food intake, possibly leading to lower energy levels and fatigue.
  3. Electrolyte Imbalance and Dehydration
    • Gastrointestinal side effects like nausea, vomiting, or diarrhea—more common with higher doses or dose escalation—can cause dehydration and electrolyte disturbances that contribute to fatigue.
  4. Central Nervous System Effects
    • GLP-1 receptors are present in the brain and may influence neurochemical pathways involved in energy regulation, mood, and alertness.
  5. Hypoglycemia (Rare)
    • Although GLP-1 agonists rarely cause hypoglycemia alone, when combined with other antidiabetic medications like sulfonylureas or insulin, low blood sugar may lead to fatigue.

Who Is Most at Risk?

  • Patients with low caloric intake
  • Those with a rapid rate of weight loss
  • Individuals with preexisting fatigue-related conditions (e.g., anemia, hypothyroidism)
  • Patients taking combination diabetes therapy

Conclusion

While GLP-1 receptor agonists offer transformative benefits for many patients, fatigue is an emerging and potentially under-recognized side effect. Understanding the underlying mechanisms and implementing thoughtful clinical strategies can help patients maximize the benefits of therapy while minimizing the burden of fatigue. Further research is needed to better define the prevalence, pathophysiology, and optimal management of GLP-1-associated fatigue.

References

  1. Nauck MA, Meier JJ. "Incretin hormones: Their role in health and disease." Diabetes Obes Metab. 2018.
  2. Wilding JPH, Batterham RL, et al. "Once-weekly semaglutide in adults with overweight or obesity." N Engl J Med. 2021.
  3. ClinicalTrials.gov and FDA product labels for GLP-1 receptor agonists.
  4. Patient-reported outcomes from online support forums and pharmacovigilance databases.

 

Back To Blog
Copyright © 2026 All Rights Reserved
Call Now
Send A Text
chevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram